Evidence browser
Explore the evidence
Loading the evidence…
Evidence browser
Loading the evidence…
Evidence browser
35,999 claims
Priority should be given to interventions in public mental health with strong evidence of effectiveness.
It is crucial that priority is given to interventions in public mental health for which there is strong evidence of effectiveness.
Policy · Policy statement · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
There is no robust evidence that a population approach to improving well-being will impact mental illness prevalence.
There is no robust evidence that a population approach to improving well-being will have any impact on the prevalence of mental illness.
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
Previous attempts to measure 'well-being' have been flawed due to incorrect assumptions.
Other research has used the results of studies from other fields and erroneously rebadged them as evidence for ‘well-being’, critically compromising the strength of the evidence base on which policy is subsequently built.
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
Mental illness and 'well-being' are not ends of the same continuum.
Mental illness and ‘well-being’ are not ends of the same continuum: it is possible to have high levels of subjective well-being despite having a mental illness, and vice versa.
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
There is no consensus on the definition of 'well-being'.
concepts as fundamental as the meaning of the term ‘well-being’ lack consensus definitions.
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
Increasing 'well-being' does not necessarily improve mental health or reduce the prevalence of mental illness.
It has been generally accepted that increasing ‘well-being’ improves mental health and reduces the prevalence of mental illness in the population i.e. that the ‘Rose’ hypothesis can be applied to public mental health. However, such conclusions are problematic...
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
The concept of 'well-being' has been increasingly used in public mental health and policy over the last six years.
The concept of ‘well-being’ has been increasingly used in public mental health and public policy over the last six years.
Context · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Public mental health: evidence based priorities (1 page summary), page 2
The CRIS system allows researchers to view de-identified records for approved studies with user engagement.
CRIS allows researchers to view de-identified records, provided research studies are approved by an oversight committee chaired by a patient and with full user engagement.
Service · Operational statement · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 80
The ClinTouch app, developed for serious mental illness, has been shown to be safe and easy to use in feasibility trials.
Feasibility trials have shown that the system is safe, provides valid data, is easy to use and is liked by users.
Service · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 77
The mHealth market was estimated to be worth US$2 billion in 2013.
Rapid developments in ICT have resulted in an established and growing global mHealth market, estimated to be worth US$2billion in 2013.
Financial · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 77
The Big White Wall digital mental health service has a recovery rate of 58% for users compared to 46% for other services.
Wandsworth Clinical Commissioning Group (CCG) have reported that users using BWW’s online therapy service have experienced a 58% recovery rate compared with 46% for other services (the UK target is 50%).
Service · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 76
Translating neuroscience research into patient benefits requires sustained support for clinical studies.
Translating neuroscience research into patient benefits requires sustained support of clinical studies testing these new approaches.
Commissioning · Policy statement · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 68
Neuroscience research is crucial to understanding the molecular and cellular mechanisms of psychiatric conditions.
It is impossible to understand the molecular and cellular mechanisms underlying psychiatric conditions such as autism and schizophrenia without these approaches.
Research · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 68
There is a mismatch between societal costs of mental illnesses and the funding for research and development.
When compared with other health problems, there is a mismatch between the societal costs of mental illnesses and the funding going into research and development for new therapeutic approaches.
Financial · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 68
Pre-clinical models are essential for understanding the biological processes that lead to mental illnesses and developing new treatments.
Using pre-clinical models (i.e. animal or cellular models) is an important approach in neuroscience research relevant to mental illness
Research · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 66
Blood-based biomarkers may predict treatment response and the development of mental illnesses.
Developing reliable blood tests for mental illnesses would represent one of the most significant advances in psychiatric practice. Ideally such tests would aid in diagnosis and in the prediction and monitoring of treatment response
Research · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 65
Gene-environment interactions may be more important than genetic effects alone in explaining mental illness.
the lack of consistent genetic findings in the GWAS of depressed patients has been partly explained by the fact that ‘gene–environment interactions’ (GxEs) might be more important than genetic effects alone
Research · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 65
Neuroimaging can predict the future course of psychotic disorders and help in early intervention.
Particular interest has been shown in the application of neuroimaging to detect patients at high risk of developing psychotic disorders. Prior to the onset of illness it appears that patients display prodromal clinical features referred to as the ‘at risk mental state’. Approximately one-third of these patients go on to develop psychotic illnesses.
Service · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 63
Pharmaceutical companies are withdrawing from brain research, which is a major concern.
It is also interesting to note that both the report from the Academy of Medical Sciences (2013)4 and the report from the ECNP5 cite the recent withdrawal of pharmaceutical companies from brain research as a source of major concern.
Policy · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 62
The funding for mental health research is significantly less than other medical fields.
mental health research spending was only 5.5% of total UK health research spending in 2009/10. This is significantly less than the proportion spent on cancer, infection, neurological disease or cardiovascular disease.
Financial · Observational claim · From Chief Medical Officer annual report 2013: public mental health — Annual report of the Chief Medical Officer 2013, page 62